Patents by Inventor Scott D. Lautenbach

Scott D. Lautenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPLANT PLACEMENT AND REMOVAL SYSTEMS
    Publication number: 20210307782
    Abstract: Devices, methods, and systems are provided for placing an implant into a patient and removing it therefrom.
    Type: Application
    Filed: December 14, 2020
    Publication date: October 7, 2021
    Inventors: Jay S. Smith, Michael R. Cole, James M. Sellers, Scott D. Lautenbach, Amy K. Whitson, Matthew Weber
  • Implant placement and removal systems
    Patent number: 10925639
    Abstract: Devices, methods, and systems are provided for placing an implant into a patient and removing it therefrom.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: February 23, 2021
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Jay S. Smith, Michael R. Cole, James M. Sellers, Scott D. Lautenbach, Amy K. Whitson, Matthew Weber
  • Osmotic delivery systems and piston assemblies for use therein
    Patent number: 10527170
    Abstract: An osmotic delivery system is disclosed for delivering an active agent formulation to a fluid environment. The osmotic delivery system typically comprises a reservoir having a lumen that contains the active agent formulation and an osmotic agent formulation and a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation. The piston assembly typically comprises a body constructed and arranged for positioning in the lumen. The body is typically made of a polymeric material that is, for example, resistant to leaching in an organic solvent. In one embodiment, the body is a columnar body having a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and the piston assembly further comprises a spring retained at the distal end of the columnar body for biasing the rim of the columnar body against the wall of the reservoir.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: January 7, 2020
    Assignee: INTARCIA THERAPEUTICS, INC.
    Inventors: Thomas R. Alessi, Michael A. DesJardin, Stan Lam, Scott D. Lautenbach, Pauline C. Zamora
  • IMPLANT PLACEMENT AND REMOVAL SYSTEMS
    Publication number: 20160354115
    Abstract: Devices, methods, and systems are provided for placing an implant into a patient and removing it therefrom.
    Type: Application
    Filed: June 2, 2016
    Publication date: December 8, 2016
    Inventors: Jay S. Smith, Michael R. Cole, James M. Sellers, Scott D. Lautenbach, Amy K. Whitson, Matthew Weber
  • Two-piece, internal-channel osmotic delivery system flow modulator
    Patent number: 8992962
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: March 31, 2015
    Assignee: Intarcia Therapeutics Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Osmotic Delivery Systems and Piston Assemblies for Use Therein
    Publication number: 20140378900
    Abstract: An osmotic delivery system is disclosed for delivering an active agent formulation to a fluid environment. The osmotic delivery system typically comprises a reservoir having a lumen that contains the active agent formulation and an osmotic agent formulation and a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation. The piston assembly typically comprises a body constructed and arranged for positioning in the lumen. The body is typically made of a polymeric material that is, for example, resistant to leaching in an organic solvent. In one embodiment, the body is a columnar body having a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and the piston assembly further comprises a spring retained at the distal end of the columnar body for biasing the rim of the columnar body against the wall of the reservoir.
    Type: Application
    Filed: June 27, 2014
    Publication date: December 25, 2014
    Inventors: Thomas R. Alessi, Michael A. DesJardin, Stan Lam, Scott D. Lautenbach, Pauline C. Zamora
  • Osmotic delivery systems and piston assemblies for use therein
    Patent number: 8801700
    Abstract: An osmotic delivery system is disclosed for delivering an active agent formulation to a fluid environment. The osmotic delivery system typically comprises a reservoir having a lumen that contains the active agent formulation and an osmotic agent formulation and a piston assembly positioned in the lumen to isolate the active agent formulation from the osmotic agent formulation. The piston assembly typically comprises a body constructed and arranged for positioning in the lumen. The body is typically made of a polymeric material that is, for example, resistant to leaching in an organic solvent. In one embodiment, the body is a columnar body having a rim at a distal end thereof for engaging and sealing against a wall of the reservoir and the piston assembly further comprises a spring retained at the distal end of the columnar body for biasing the rim of the columnar body against the wall of the reservoir.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: August 12, 2014
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Thomas R. Alessi, Michael A. DesJardin, Stan Lam, Scott D. Lautenbach, Pauline C. Zamora
  • TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
    Publication number: 20130247376
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Sustained delivery of an active agent using an implantable system
    Patent number: 8535701
    Abstract: The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: September 17, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: John R. Peery, Keith E. Dionne, Felix A. Landrau, Bonnie J. Eckenhoff, Scott D. Lautenbach, Judy A. Magruder, Jeremy C. Wright
  • Two-piece, internal-channel osmotic delivery system flow modulator
    Patent number: 8470353
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: January 12, 2013
    Date of Patent: June 25, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
    Publication number: 20130138089
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: January 12, 2013
    Publication date: May 30, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • SUSTAINED DELIVERY OF AN ACTIVE AGENT USING AN IMPLANTABLE SYSTEM
    Publication number: 20130035669
    Abstract: The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
    Type: Application
    Filed: October 4, 2012
    Publication date: February 7, 2013
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: John R. Peery, Keith E. Dionne, Felix A. Landrau, Scott D. Lautenbach, Judy A. Magruder, Jeremy C. Wright, Bonnie J. Eckenhoff
  • Two-piece, internal-channel osmotic delivery system flow modulator
    Patent number: 8367095
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: February 5, 2013
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
    Publication number: 20120330282
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: August 31, 2012
    Publication date: December 27, 2012
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Sustained delivery of an active agent using an implantable system
    Patent number: 8298562
    Abstract: The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: October 30, 2012
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: John R. Peery, Keith E. Dionne, James B. Eckenhoff, Bonnie J. Eckenhoff, legal representative, Felix A. Landrau, Scott D. Lautenbach, Judy A. Magruder, Jeremy C. Wright
  • Two-piece, internal-channel osmotic delivery system flow modulator
    Patent number: 8273365
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: September 25, 2012
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
    Publication number: 20120184945
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 19, 2012
    Applicant: INTARCIA THERAPEUTICS, INC.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Two-piece, internal-channel osmotic delivery system flow modulator
    Patent number: 8158150
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: April 17, 2012
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin
  • Sustained delivery of an active agent using an implantable system
    Patent number: 8080259
    Abstract: The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: December 20, 2011
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: John R. Peery, Keith E. Dionne, James B. Eckenhoff, Felix A. Landrau, Scott D. Lautenbach, Judy A. Magruder, Jeremy C. Wright
  • TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR
    Publication number: 20110301576
    Abstract: An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system.
    Type: Application
    Filed: August 12, 2011
    Publication date: December 8, 2011
    Inventors: Scott D. Lautenbach, Pedro E. de la Serna, Pauline C. Zamora, Michael A. DesJardin